(Q39436280)

12 September 2017

title

Infarct size reduction: a review of the clinical trials (English)

1 reference

12 September 2017

Campbell CA

1

1 reference

12 September 2017

Przyklenk K

series ordinal

2

1 reference

12 September 2017

Kloner RA

series ordinal

3

1 reference

12 September 2017

publication date

1 May 1986

1 reference

The Journal of Clinical Pharmacology

12 September 2017

published in

1 reference

12 September 2017

volume

26

1 reference

12 September 2017

issue

5

1 reference

12 September 2017

page(s)

317-329

1 reference

Natural history of acute coronary heart attacks. A community study

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

Incidence and presentation of myocardial infarction in an English community

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

Coronary heart-attacks in East London

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

Estimation of Infarct Size in Man and its Relation to Prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

Treatment of acute myocardial infarction with propranolol. Further studies on enzyme appearance and subsequent left ventricular function in treated and control patients with developing infarcts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

Cause and course of acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

Experimental myocardial infarction: XII. Dynamic changes in segmental mechanical behavior of infarcted and non-infarcted myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

Experimental myocardial infarction. XVI. The detection of inotropic contractile reserve with postextrasystolic potentiation in acutely ischemic canine myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

Use of changes in the epicardial QRS complex to assess interventions which modify the extent of myocardial necrosis following coronary artery occlusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

The stunned myocardium: prolonged, postischemic ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

Quantitative assessment of the extent of myocardial infarction in the conscious dog by means of analysis of serial changes in serum creatine phosphokinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

An improved basis for enzymatic estimation of infarct size

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

Attempt to quantitate relation between cardiac function and infarct size in acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

Estimation of acute myocardial infarct size in man by serum CK-MB measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

Two and three dimensional display of myocardial ischemic “border zone” in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

Relationship between Epicardial S-T Segment Changes and Myocardial Metabolism during Acute Coronary Insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

Changes in intramyocardial ST segment voltage and gas tensions with regional myocardial ischemia in the dog

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

Long-term preservation of ischemic myocardium in the dog by hyaluronidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

Factors influencing infarct size following experimental coronary artery occlusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

Observations on experimental myocardial ischaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

Propranolol decreases sympathetic nervous activity reflected by plasma catecholamines during evolution of myocardial infarction in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

Effect of propranolol on regional myocardial blood flow in acute ischaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

Effects of propranolol on regional myocardial function, electrograms, and blood flow in conscious dogs with myocardial ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

The effect of delay in propranolol administration on reduction of myocardial infarct size after experimental coronary artery occlusion in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

Prolonged protective effect of propranolol on hypoxic heart muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

On the nature of protection by propranolol against myocardial necrosis after temporary coronary occlusion in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

Beta blockade during and after myocardial infarction: an overview of the randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

Reduction of Infarct Size with the Early Use of Timolol in Acute Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

Protective effect of propranolol in threatened myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

Effect of propranolol on myocardial-infarct size in a randomized blinded multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

Thrombolytic therapy in patients with acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

Effects of coronary artery reperfusion on myocardial infarct size calculated from creatine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

Intracoronary thrombolysis in evolving myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

Prevention of myocardial damage in acute myocardial ischemia by early treatment with intravenous streptokinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

Intravenous urokinase in acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

Autoradiographic method for measuring the ischemic myocardium at risk: effects of verapamil on infarct size aftr experimental coronary artery occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

The effects of nifedipine on acute experimental myocardial ischemia and infarction in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

Calcium Channel Blocking Agents in the Treatment of Cardiovascular Disorders. Part I: Basic and Clinical Electrophysiologic Effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

Calcium channel blocking agents in the treatment of cardiovascular disorders. Part II: Hemodynamic effects and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

Reduction of creatine kinase and creatine kinase-MB indexes of infarct size by intravenous verapamil

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

Nifedipine therapy for patients with threatened and acute myocardial infarction: a randomized, double-blind, placebo-controlled comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

Evolution of infarct size during the early use of nifedipine in patients with acute myocardial infarction: the Norwegian Nifedipine Multicenter Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

Reduction of CK and CK-MB indexes of infarct size by intravenous nitroglycerin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

Reduction of infarct size in patients with inferior infarction with intravenous glyceryl trinitrate. A randomised study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

A randomized prospective trial of intravenous nitroglycerin in patients with acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

Beneficial effects of intravenous nitroglycerin on haemodynamics and enzymatically estimated infarct size

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

Effect of short-term infusion of sodium nitroprusside on mortality rate in acute myocardial infarction complicated by left ventricular failure: results of a Veterans Administration cooperative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

Comparison between the effects of nitroprusside and nitroglycerin on ischemic injury during acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

A Randomized Controlled Trial of Acetyl Salicyclic Acid in the Secondary Prevention of Mortality from Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

Aspirin and secondary mortality after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

Are agents affecting platelet functions clinically useful?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

Ventricular septal rupture during ibuprofen therapy for pericarditis after acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

Protective action of methylprednisolone on the myocardium during experimental myocardial ischemia in the cat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

Reduction of Experimental Myocardial Infarct Size by Corticosteroid Administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

Inability of methylprednisolone sodium succinate to decrease infarct size or preserve enzyme activity measured 24 hours after coronary occlusion in the dog

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

Use of hydrocortisone in the treatment of acute myocardial infarction. Summary of a clinical trial in 446 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

Effect of Therapy with Methylprednisolone on the Size of Myocardial Infarcts in Man

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

Failure of methylprednisolone to protect acutely ischemic myocardium: a contrast with subsequent beta-adrenergic blockade in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

The mechanism of action of a single dose of methylprednisolone on acute inflammation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

Hyaluronidase-induced reductions in myocardial infarct size

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

The influence of the time interval between coronary artery occlusion and the administration of hyaluronidase on salvage of ischemic myocardium in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

Effects of early administration of a highly purified hyaluronidase preparation (GL enzyme) on myocardial infarct size

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

Intravenous hyaluronidase therapy for myocardial infarction in man: double-blind trial to assess infarct size limitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

The Biology of Oxygen Radicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

Role of oxygen radicals in cardiac injury due to reoxygenation*

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

Percutaneous transluminal coronary angioplasty with and without thrombolytic therapy for treatment of acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB03532.X

10.1002/J.1552-4604.1986.TB03532.X

21 January 2018

Identifiers

DOI

1 reference

12 September 2017

1 reference